0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Intelligence Medical Product Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-17T17037
Home | Market Reports | Health| Medical Devices & Equipment
Global Artificial Intelligence Medical Product Market Research Report 2024
BUY CHAPTERS

Global Artificial Intelligence Medical Product Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17T17037
Report
November 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Intelligence Medical Product Market

The global Artificial Intelligence Medical Product market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Medical Institutions accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Artificial Intelligence Medical Product leading manufacturers including Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc., dominate supply; the top five capture approximately % of global revenue, with Airdoc Technology leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Intelligence Medical Product market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Artificial Intelligence Medical Product Market Report

Report Metric Details
Report Name Artificial Intelligence Medical Product Market
Segment by Type
  • Endocrine Disease
  • Cardiovascular Disease
  • Eye Disease
  • Others
Segment by Application
  • Medical Institutions
  • Great Health Scene
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Deepwise, BEIJING INFERVISION TECHNOLOGY, Shanghai Lianying Intelligent Medical Technology, Shukun Technology, Shenzhen Keya Medical Technology, Shenzhen Ruixin Intelligent Medical Technology, YITU Technology, Beijing Huiyi Huiying Medical Technology, BioMind
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Artificial Intelligence Medical Product study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Artificial Intelligence Medical Product Market report?

Ans: The main players in the Artificial Intelligence Medical Product Market are Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Deepwise, BEIJING INFERVISION TECHNOLOGY, Shanghai Lianying Intelligent Medical Technology, Shukun Technology, Shenzhen Keya Medical Technology, Shenzhen Ruixin Intelligent Medical Technology, YITU Technology, Beijing Huiyi Huiying Medical Technology, BioMind

What are the Application segmentation covered in the Artificial Intelligence Medical Product Market report?

Ans: The Applications covered in the Artificial Intelligence Medical Product Market report are Medical Institutions, Great Health Scene

What are the Type segmentation covered in the Artificial Intelligence Medical Product Market report?

Ans: The Types covered in the Artificial Intelligence Medical Product Market report are Endocrine Disease, Cardiovascular Disease, Eye Disease, Others

1 Study Coverage
1.1 Introduction to Artificial Intelligence Medical Product: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Intelligence Medical Product Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Endocrine Disease
1.2.3 Cardiovascular Disease
1.2.4 Eye Disease
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Artificial Intelligence Medical Product Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Institutions
1.3.3 Great Health Scene
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Intelligence Medical Product Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Intelligence Medical Product Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Artificial Intelligence Medical Product Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Artificial Intelligence Medical Product Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Endocrine Disease Market Size by Players
3.3.2 Cardiovascular Disease Market Size by Players
3.3.3 Eye Disease Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Artificial Intelligence Medical Product Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Intelligence Medical Product Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Intelligence Medical Product Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Artificial Intelligence Medical Product Market Size by Type (2020-2031)
6.4 North America Artificial Intelligence Medical Product Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Intelligence Medical Product Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Artificial Intelligence Medical Product Market Size by Type (2020-2031)
7.4 Europe Artificial Intelligence Medical Product Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Intelligence Medical Product Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Artificial Intelligence Medical Product Market Size by Type (2020-2031)
8.4 Asia-Pacific Artificial Intelligence Medical Product Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Artificial Intelligence Medical Product Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Artificial Intelligence Medical Product Market Size by Type (2020-2031)
9.4 Central and South America Artificial Intelligence Medical Product Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Intelligence Medical Product Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Artificial Intelligence Medical Product Market Size by Type (2020-2031)
10.4 Middle East and Africa Artificial Intelligence Medical Product Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Intelligence Medical Product Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Airdoc Technology
11.1.1 Airdoc Technology Corporation Information
11.1.2 Airdoc Technology Business Overview
11.1.3 Airdoc Technology Artificial Intelligence Medical Product Product Features and Attributes
11.1.4 Airdoc Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.1.5 Airdoc Technology Artificial Intelligence Medical Product Revenue by Product in 2024
11.1.6 Airdoc Technology Artificial Intelligence Medical Product Revenue by Application in 2024
11.1.7 Airdoc Technology Artificial Intelligence Medical Product Revenue by Geographic Area in 2024
11.1.8 Airdoc Technology Artificial Intelligence Medical Product SWOT Analysis
11.1.9 Airdoc Technology Recent Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Corporation Information
11.2.2 Digital Diagnostics Business Overview
11.2.3 Digital Diagnostics Artificial Intelligence Medical Product Product Features and Attributes
11.2.4 Digital Diagnostics Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.2.5 Digital Diagnostics Artificial Intelligence Medical Product Revenue by Product in 2024
11.2.6 Digital Diagnostics Artificial Intelligence Medical Product Revenue by Application in 2024
11.2.7 Digital Diagnostics Artificial Intelligence Medical Product Revenue by Geographic Area in 2024
11.2.8 Digital Diagnostics Artificial Intelligence Medical Product SWOT Analysis
11.2.9 Digital Diagnostics Recent Developments
11.3 Eyenuk
11.3.1 Eyenuk Corporation Information
11.3.2 Eyenuk Business Overview
11.3.3 Eyenuk Artificial Intelligence Medical Product Product Features and Attributes
11.3.4 Eyenuk Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.3.5 Eyenuk Artificial Intelligence Medical Product Revenue by Product in 2024
11.3.6 Eyenuk Artificial Intelligence Medical Product Revenue by Application in 2024
11.3.7 Eyenuk Artificial Intelligence Medical Product Revenue by Geographic Area in 2024
11.3.8 Eyenuk Artificial Intelligence Medical Product SWOT Analysis
11.3.9 Eyenuk Recent Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Corporation Information
11.4.2 RetinaLyze System Business Overview
11.4.3 RetinaLyze System Artificial Intelligence Medical Product Product Features and Attributes
11.4.4 RetinaLyze System Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.4.5 RetinaLyze System Artificial Intelligence Medical Product Revenue by Product in 2024
11.4.6 RetinaLyze System Artificial Intelligence Medical Product Revenue by Application in 2024
11.4.7 RetinaLyze System Artificial Intelligence Medical Product Revenue by Geographic Area in 2024
11.4.8 RetinaLyze System Artificial Intelligence Medical Product SWOT Analysis
11.4.9 RetinaLyze System Recent Developments
11.5 Optomed
11.5.1 Optomed Corporation Information
11.5.2 Optomed Business Overview
11.5.3 Optomed Artificial Intelligence Medical Product Product Features and Attributes
11.5.4 Optomed Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.5.5 Optomed Artificial Intelligence Medical Product Revenue by Product in 2024
11.5.6 Optomed Artificial Intelligence Medical Product Revenue by Application in 2024
11.5.7 Optomed Artificial Intelligence Medical Product Revenue by Geographic Area in 2024
11.5.8 Optomed Artificial Intelligence Medical Product SWOT Analysis
11.5.9 Optomed Recent Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Corporation Information
11.6.2 Sibionics Technology Business Overview
11.6.3 Sibionics Technology Artificial Intelligence Medical Product Product Features and Attributes
11.6.4 Sibionics Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.6.5 Sibionics Technology Recent Developments
11.7 Aeye Health
11.7.1 Aeye Health Corporation Information
11.7.2 Aeye Health Business Overview
11.7.3 Aeye Health Artificial Intelligence Medical Product Product Features and Attributes
11.7.4 Aeye Health Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.7.5 Aeye Health Recent Developments
11.8 VUNO
11.8.1 VUNO Corporation Information
11.8.2 VUNO Business Overview
11.8.3 VUNO Artificial Intelligence Medical Product Product Features and Attributes
11.8.4 VUNO Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.8.5 VUNO Recent Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Corporation Information
11.9.2 Medimaging Integrated Solution Business Overview
11.9.3 Medimaging Integrated Solution Artificial Intelligence Medical Product Product Features and Attributes
11.9.4 Medimaging Integrated Solution Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.9.5 Medimaging Integrated Solution Recent Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Corporation Information
11.10.2 EyRIS (SELENA+) Business Overview
11.10.3 EyRIS (SELENA+) Artificial Intelligence Medical Product Product Features and Attributes
11.10.4 EyRIS (SELENA+) Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Vistel
11.11.1 Vistel Corporation Information
11.11.2 Vistel Business Overview
11.11.3 Vistel Artificial Intelligence Medical Product Product Features and Attributes
11.11.4 Vistel Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.11.5 Vistel Recent Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Corporation Information
11.12.2 RETINA-AI Health Business Overview
11.12.3 RETINA-AI Health Artificial Intelligence Medical Product Product Features and Attributes
11.12.4 RETINA-AI Health Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.12.5 RETINA-AI Health Recent Developments
11.13 Deepwise
11.13.1 Deepwise Corporation Information
11.13.2 Deepwise Business Overview
11.13.3 Deepwise Artificial Intelligence Medical Product Product Features and Attributes
11.13.4 Deepwise Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.13.5 Deepwise Recent Developments
11.14 BEIJING INFERVISION TECHNOLOGY
11.14.1 BEIJING INFERVISION TECHNOLOGY Corporation Information
11.14.2 BEIJING INFERVISION TECHNOLOGY Business Overview
11.14.3 BEIJING INFERVISION TECHNOLOGY Artificial Intelligence Medical Product Product Features and Attributes
11.14.4 BEIJING INFERVISION TECHNOLOGY Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.14.5 BEIJING INFERVISION TECHNOLOGY Recent Developments
11.15 Shanghai Lianying Intelligent Medical Technology
11.15.1 Shanghai Lianying Intelligent Medical Technology Corporation Information
11.15.2 Shanghai Lianying Intelligent Medical Technology Business Overview
11.15.3 Shanghai Lianying Intelligent Medical Technology Artificial Intelligence Medical Product Product Features and Attributes
11.15.4 Shanghai Lianying Intelligent Medical Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.15.5 Shanghai Lianying Intelligent Medical Technology Recent Developments
11.16 Shukun Technology
11.16.1 Shukun Technology Corporation Information
11.16.2 Shukun Technology Business Overview
11.16.3 Shukun Technology Artificial Intelligence Medical Product Product Features and Attributes
11.16.4 Shukun Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.16.5 Shukun Technology Recent Developments
11.17 Shenzhen Keya Medical Technology
11.17.1 Shenzhen Keya Medical Technology Corporation Information
11.17.2 Shenzhen Keya Medical Technology Business Overview
11.17.3 Shenzhen Keya Medical Technology Artificial Intelligence Medical Product Product Features and Attributes
11.17.4 Shenzhen Keya Medical Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.17.5 Shenzhen Keya Medical Technology Recent Developments
11.18 Shenzhen Ruixin Intelligent Medical Technology
11.18.1 Shenzhen Ruixin Intelligent Medical Technology Corporation Information
11.18.2 Shenzhen Ruixin Intelligent Medical Technology Business Overview
11.18.3 Shenzhen Ruixin Intelligent Medical Technology Artificial Intelligence Medical Product Product Features and Attributes
11.18.4 Shenzhen Ruixin Intelligent Medical Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.18.5 Shenzhen Ruixin Intelligent Medical Technology Recent Developments
11.19 YITU Technology
11.19.1 YITU Technology Corporation Information
11.19.2 YITU Technology Business Overview
11.19.3 YITU Technology Artificial Intelligence Medical Product Product Features and Attributes
11.19.4 YITU Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.19.5 YITU Technology Recent Developments
11.20 Beijing Huiyi Huiying Medical Technology
11.20.1 Beijing Huiyi Huiying Medical Technology Corporation Information
11.20.2 Beijing Huiyi Huiying Medical Technology Business Overview
11.20.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence Medical Product Product Features and Attributes
11.20.4 Beijing Huiyi Huiying Medical Technology Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.20.5 Beijing Huiyi Huiying Medical Technology Recent Developments
11.21 BioMind
11.21.1 BioMind Corporation Information
11.21.2 BioMind Business Overview
11.21.3 BioMind Artificial Intelligence Medical Product Product Features and Attributes
11.21.4 BioMind Artificial Intelligence Medical Product Revenue and Gross Margin (2020-2025)
11.21.5 BioMind Recent Developments
12 Artificial Intelligence Medical ProductIndustry Chain Analysis
12.1 Artificial Intelligence Medical Product Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Intelligence Medical Product Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Intelligence Medical Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Artificial Intelligence Medical Product Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Artificial Intelligence Medical Product Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Artificial Intelligence Medical Product Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Artificial Intelligence Medical Product Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Artificial Intelligence Medical Product Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Artificial Intelligence Medical Product Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Artificial Intelligence Medical Product by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Medical Product as of 2024)
 Table 11. Global Artificial Intelligence Medical Product Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Artificial Intelligence Medical Product Companies Headquarters
 Table 13. Global Artificial Intelligence Medical Product Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Artificial Intelligence Medical Product Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Artificial Intelligence Medical Product Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Artificial Intelligence Medical Product Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Artificial Intelligence Medical Product Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Artificial Intelligence Medical Product High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Artificial Intelligence Medical Product Growth Accelerators and Market Barriers
 Table 25. North America Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Artificial Intelligence Medical Product Growth Accelerators and Market Barriers
 Table 27. Europe Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Artificial Intelligence Medical Product Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Artificial Intelligence Medical Product Investment Opportunities and Key Challenges
 Table 31. Central and South America Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Artificial Intelligence Medical Product Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Artificial Intelligence Medical Product Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Airdoc Technology Corporation Information
 Table 35. Airdoc Technology Description and Major Businesses
 Table 36. Airdoc Technology Product Features and Attributes
 Table 37. Airdoc Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Airdoc Technology Revenue Proportion by Product in 2024
 Table 39. Airdoc Technology Revenue Proportion by Application in 2024
 Table 40. Airdoc Technology Revenue Proportion by Geographic Area in 2024
 Table 41. Airdoc Technology Artificial Intelligence Medical Product SWOT Analysis
 Table 42. Airdoc Technology Recent Developments
 Table 43. Digital Diagnostics Corporation Information
 Table 44. Digital Diagnostics Description and Major Businesses
 Table 45. Digital Diagnostics Product Features and Attributes
 Table 46. Digital Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Digital Diagnostics Revenue Proportion by Product in 2024
 Table 48. Digital Diagnostics Revenue Proportion by Application in 2024
 Table 49. Digital Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 50. Digital Diagnostics Artificial Intelligence Medical Product SWOT Analysis
 Table 51. Digital Diagnostics Recent Developments
 Table 52. Eyenuk Corporation Information
 Table 53. Eyenuk Description and Major Businesses
 Table 54. Eyenuk Product Features and Attributes
 Table 55. Eyenuk Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Eyenuk Revenue Proportion by Product in 2024
 Table 57. Eyenuk Revenue Proportion by Application in 2024
 Table 58. Eyenuk Revenue Proportion by Geographic Area in 2024
 Table 59. Eyenuk Artificial Intelligence Medical Product SWOT Analysis
 Table 60. Eyenuk Recent Developments
 Table 61. RetinaLyze System Corporation Information
 Table 62. RetinaLyze System Description and Major Businesses
 Table 63. RetinaLyze System Product Features and Attributes
 Table 64. RetinaLyze System Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. RetinaLyze System Revenue Proportion by Product in 2024
 Table 66. RetinaLyze System Revenue Proportion by Application in 2024
 Table 67. RetinaLyze System Revenue Proportion by Geographic Area in 2024
 Table 68. RetinaLyze System Artificial Intelligence Medical Product SWOT Analysis
 Table 69. RetinaLyze System Recent Developments
 Table 70. Optomed Corporation Information
 Table 71. Optomed Description and Major Businesses
 Table 72. Optomed Product Features and Attributes
 Table 73. Optomed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Optomed Revenue Proportion by Product in 2024
 Table 75. Optomed Revenue Proportion by Application in 2024
 Table 76. Optomed Revenue Proportion by Geographic Area in 2024
 Table 77. Optomed Artificial Intelligence Medical Product SWOT Analysis
 Table 78. Optomed Recent Developments
 Table 79. Sibionics Technology Corporation Information
 Table 80. Sibionics Technology Description and Major Businesses
 Table 81. Sibionics Technology Product Features and Attributes
 Table 82. Sibionics Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sibionics Technology Recent Developments
 Table 84. Aeye Health Corporation Information
 Table 85. Aeye Health Description and Major Businesses
 Table 86. Aeye Health Product Features and Attributes
 Table 87. Aeye Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Aeye Health Recent Developments
 Table 89. VUNO Corporation Information
 Table 90. VUNO Description and Major Businesses
 Table 91. VUNO Product Features and Attributes
 Table 92. VUNO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. VUNO Recent Developments
 Table 94. Medimaging Integrated Solution Corporation Information
 Table 95. Medimaging Integrated Solution Description and Major Businesses
 Table 96. Medimaging Integrated Solution Product Features and Attributes
 Table 97. Medimaging Integrated Solution Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Medimaging Integrated Solution Recent Developments
 Table 99. EyRIS (SELENA+) Corporation Information
 Table 100. EyRIS (SELENA+) Description and Major Businesses
 Table 101. EyRIS (SELENA+) Product Features and Attributes
 Table 102. EyRIS (SELENA+) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. EyRIS (SELENA+) Recent Developments
 Table 104. Vistel Corporation Information
 Table 105. Vistel Description and Major Businesses
 Table 106. Vistel Product Features and Attributes
 Table 107. Vistel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Vistel Recent Developments
 Table 109. RETINA-AI Health Corporation Information
 Table 110. RETINA-AI Health Description and Major Businesses
 Table 111. RETINA-AI Health Product Features and Attributes
 Table 112. RETINA-AI Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. RETINA-AI Health Recent Developments
 Table 114. Deepwise Corporation Information
 Table 115. Deepwise Description and Major Businesses
 Table 116. Deepwise Product Features and Attributes
 Table 117. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Deepwise Recent Developments
 Table 119. BEIJING INFERVISION TECHNOLOGY Corporation Information
 Table 120. BEIJING INFERVISION TECHNOLOGY Description and Major Businesses
 Table 121. BEIJING INFERVISION TECHNOLOGY Product Features and Attributes
 Table 122. BEIJING INFERVISION TECHNOLOGY Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. BEIJING INFERVISION TECHNOLOGY Recent Developments
 Table 124. Shanghai Lianying Intelligent Medical Technology Corporation Information
 Table 125. Shanghai Lianying Intelligent Medical Technology Description and Major Businesses
 Table 126. Shanghai Lianying Intelligent Medical Technology Product Features and Attributes
 Table 127. Shanghai Lianying Intelligent Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Shanghai Lianying Intelligent Medical Technology Recent Developments
 Table 129. Shukun Technology Corporation Information
 Table 130. Shukun Technology Description and Major Businesses
 Table 131. Shukun Technology Product Features and Attributes
 Table 132. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Shukun Technology Recent Developments
 Table 134. Shenzhen Keya Medical Technology Corporation Information
 Table 135. Shenzhen Keya Medical Technology Description and Major Businesses
 Table 136. Shenzhen Keya Medical Technology Product Features and Attributes
 Table 137. Shenzhen Keya Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Shenzhen Keya Medical Technology Recent Developments
 Table 139. Shenzhen Ruixin Intelligent Medical Technology Corporation Information
 Table 140. Shenzhen Ruixin Intelligent Medical Technology Description and Major Businesses
 Table 141. Shenzhen Ruixin Intelligent Medical Technology Product Features and Attributes
 Table 142. Shenzhen Ruixin Intelligent Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Shenzhen Ruixin Intelligent Medical Technology Recent Developments
 Table 144. YITU Technology Corporation Information
 Table 145. YITU Technology Description and Major Businesses
 Table 146. YITU Technology Product Features and Attributes
 Table 147. YITU Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. YITU Technology Recent Developments
 Table 149. Beijing Huiyi Huiying Medical Technology Corporation Information
 Table 150. Beijing Huiyi Huiying Medical Technology Description and Major Businesses
 Table 151. Beijing Huiyi Huiying Medical Technology Product Features and Attributes
 Table 152. Beijing Huiyi Huiying Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Beijing Huiyi Huiying Medical Technology Recent Developments
 Table 154. BioMind Corporation Information
 Table 155. BioMind Description and Major Businesses
 Table 156. BioMind Product Features and Attributes
 Table 157. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. BioMind Recent Developments
 Table 159. Raw Materials Key Suppliers
 Table 160. Distributors List
 Table 161. Market Trends and Market Evolution
 Table 162. Market Drivers and Opportunities
 Table 163. Market Challenges, Risks, and Restraints
 Table 164. Research Programs/Design for This Report
 Table 165. Key Data Information from Secondary Sources
 Table 166. Key Data Information from Primary Sources


List of Figures
 Figure 1. Artificial Intelligence Medical Product Product Picture
 Figure 2. Global Artificial Intelligence Medical Product Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Endocrine Disease Product Picture
 Figure 4. Cardiovascular Disease Product Picture
 Figure 5. Eye Disease Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Artificial Intelligence Medical Product Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Medical Institutions
 Figure 9. Great Health Scene
 Figure 10. Artificial Intelligence Medical Product Report Years Considered
 Figure 11. Global Artificial Intelligence Medical Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Artificial Intelligence Medical Product Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Artificial Intelligence Medical Product Revenue Market Share by Region (2020-2031)
 Figure 15. Global Artificial Intelligence Medical Product Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Endocrine Disease Revenue Market Share by Player in 2024
 Figure 18. Cardiovascular Disease Revenue Market Share by Player in 2024
 Figure 19. Eye Disease Revenue Market Share by Player in 2024
 Figure 20. Others Revenue Market Share by Player in 2024
 Figure 21. Global Artificial Intelligence Medical Product Revenue Market Share by Type (2020-2031)
 Figure 22. Global Artificial Intelligence Medical Product Revenue Market Share by Application (2020-2031)
 Figure 23. North America Artificial Intelligence Medical Product Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players Artificial Intelligence Medical Product Revenue (US$ Million) in 2024
 Figure 25. North America Artificial Intelligence Medical Product Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America Artificial Intelligence Medical Product Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe Artificial Intelligence Medical Product Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players Artificial Intelligence Medical Product Revenue (US$ Million) in 2024
 Figure 32. Europe Artificial Intelligence Medical Product Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe Artificial Intelligence Medical Product Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 35. France Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Artificial Intelligence Medical Product Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players Artificial Intelligence Medical Product Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific Artificial Intelligence Medical Product Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific Artificial Intelligence Medical Product Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 47. India Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore Artificial Intelligence Medical Product Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America Artificial Intelligence Medical Product Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players Artificial Intelligence Medical Product Revenue (US$ Million) in 2024
 Figure 55. Central and South America Artificial Intelligence Medical Product Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America Artificial Intelligence Medical Product Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa Artificial Intelligence Medical Product Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players Artificial Intelligence Medical Product Revenue (US$ Million) in 2024
 Figure 61. South America Artificial Intelligence Medical Product Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa Artificial Intelligence Medical Product Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa Artificial Intelligence Medical Product Revenue (2020-2025) & (US$ Million)
 Figure 67. Artificial Intelligence Medical Product Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart